Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott infant formula suit

This article was originally published in The Tan Sheet

Executive Summary

Antitrust case brought by the Federal Trade Commission is set to go to trial on Sept. 7. Abbott attended a pretrial hearing on July 29. In 1992, FTC filed two complaints alleging that Abbott's "anti-competitive behavior" in the infant formula market was exclusionary, and that its "lockstep" pricing strategies effectively defrauded the Puerto Rican Special Supplemental Food Program for Women, Infants, and Children. Abbott has paid more than $ 100 mil. in settlements, most recently to 21 wholesalers and retailers involved in a suit in Florida ("The Tan Sheet" May 31, p. 9).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS081736

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel